In-vitro haemocompatibility of dextran-protein submicron particles

References

• Jao D, Xue Y, Medina J, et al. Protein-based drug-delivery materials. Materials (Basel) 2017;10:1–24.
   Web of Science ®Google Scholar
• Nitta SK, Numata K. Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci. 2013;14:1629–1654.
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release. 2012;161:38–49.
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157:168–182.
   PubMed Web of Science ®Google Scholar
• Lohcharoenkal W, Wang L, Chen YC, et al. Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Hawkins MJ, Soon-Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine [Internet]. Adv Drug Deliv Rev. 2008;60:876–885.
   PubMed Web of Science ®Google Scholar
• Kudarha RR, Sawant KK. Albumin based versatile multifunctional nanocarriers for cancer therapy: fabrication, surface modification, multimodal therapeutics and imaging approaches. Mater Sci Eng C. 2017;81:607–626.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Steffen A, Andreas K, et al. Hemoglobin-based oxygen carrier microparticles: synthesis, properties, and in vitro and in vivo investigations. Biomacromolecules. 2012;13:3292–3300.
   PubMed Web of Science ®Google Scholar
• Bäumler H, Xiong Y, Liu ZZ, et al. Novel hemoglobin particles-promising new-generation hemoglobin-based oxygen carriers. Artif Organs. 2014;38:708–714.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Liu ZZ, Georgieva R, et al. Nonvasoconstrictive hemoglobin particles as oxygen carriers. ACS Nano. 2013;7:7454–7461.
   PubMed Web of Science ®Google Scholar
• Jia Y, Duan L, Li J. Hemoglobin-based nanoarchitectonic assemblies as oxygen carriers. Adv Mater. 2016;28:1312–1318.
   PubMed Web of Science ®Google Scholar
• Tao Z, Peter Ghoroghchian P. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes. Trends Biotechnol. 2014;32:466–473.
   PubMed Web of Science ®Google Scholar
• De Frates K, Markiewicz T, Gallo P, et al. Protein polymer-based nanoparticles: fabrication and medical applications. Int J Mol Sci. 2018;19:1–20.
   Web of Science ®Google Scholar
• Duan L, Yan X, Wang A, et al. Highly loaded hemoglobin spheres as promising artificial oxygen carriers. ACS Nano. 2012;6:6897–6904.
   PubMed Web of Science ®Google Scholar
• Tsuchida E, Sou K, Nakagawa A, et al. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjugate Chem. 2009;20:1419–1440.
   PubMed Web of Science ®Google Scholar
• Piras AM, Dessy A, Chiellini F, et al. Polymeric nanoparticles for hemoglobin-based oxygen carriers. Biochim Biophys Acta - Proteins Proteomics. 2008;1784:1454–1461.
   PubMed Web of Science ®Google Scholar
• Naeye B, Deschout H, Röding M, et al. Hemocompatibility of siRNA loaded dextran nanogels. Biomaterials. 2011;32:9120–9127.
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Aggarwal P, Hall JB, et al. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5:487–495.
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles [Internet]. Int J Pharm. 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1–16.
   PubMed Web of Science ®Google Scholar
• Mayer A, Vadon M, Rinner B, et al. The role of nanoparticle size in hemocompatibility. Toxicology. 2009;258:139–147.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Appl Phys Sci. 2008;105:14265–14270.
   Google Scholar
• Kloypan C, Prapan A, Suwannasom N, et al. Improved oxygen storage capacity of haemoglobin submicron particles by one-pot formulation. Artif Cells, Blood Substit Biotechnol. 2018; doi:10.1080/21691401.2018.1521819
   Google Scholar
• Berillo D, Elowsson L, Kirsebom H. Oxidized dextran as crosslinker for chitosan cryogel scaffolds and formation of polyelectrolyte complexes between chitosan and gelatin. Macromol Biosci. 2012;12:1090–1099.
   PubMed Web of Science ®Google Scholar
• Lisman A, Butruk B, Wasiak I, et al. Dextran/albumin hydrogel sealant for Dacron(R) vascular prosthesis. J Biomater Appl. 2014;28:1386–1396.
   PubMed Web of Science ®Google Scholar
• Lu M, Zhao C, Wang Q, et al. Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers. Colloids Surf B Biointerfaces. 2016 ;1:171–179.
   Web of Science ®Google Scholar
• Braune S, Walter M, Schulze F, et al. Changes in platelet morphology and function during 24 hours of storage. Clin Hemorheol Microcirc. 2014;58:159–170.
   PubMed Web of Science ®Google Scholar
• Cuyper IMD, Meinders M, Vijver EVD, et al. A novel fl ow cytometry – based platelet aggregation assay. Blood. 2013;121:70–80.
   Web of Science ®Google Scholar
• Ba¨umler H, Georgieva R. Coupled enzyme reactions in multicompartment microparticles. Biomacromolecules. 2010;11:1480–1487.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Georgieva R, Steffen A, et al. Structure and properties of hybrid biopolymer particles fabricated by co-precipitation cross-linking dissolution procedure. J Colloid Interface Sci. 2018;15:156–164.
   Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, et al. Toxic potential of materials at the nanolevel [Internet]. Science. 2006;311:622–627.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–951.
   PubMed Web of Science ®Google Scholar
• Tanzi MC. Bioactive technologies for hemocompatibility. Expert Rev Med Devices. 2005;2:473–492.
   PubMed Web of Science ®Google Scholar
• Helms CC, Marvel M, Zhao W, et al. Mechanisms of hemolysis-associated platelet activation. J Thromb Haemost. 2013;11:2148–2154.
   PubMed Web of Science ®Google Scholar
• Elci SG, Jiang Y, Yan B, et al. Surface charge controls the suborgan biodistributions of gold nanoparticles. ACS Nano. 2016;10:5536–5542.
   PubMed Web of Science ®Google Scholar
• Bäumler H, Donath E, Krabi A, et al. Electrophoresis of human red blood cells and platelets. Evidence for depletion of dextran. Biorheology. 1996; 33:333–351.
   PubMed Web of Science ®Google Scholar
• Bäumler H, Neu B, Donath E, et al. Basic phenomena of red blood cell rouleaux formation. Biorheology. 1999; 36:439–442.
   PubMed Web of Science ®Google Scholar